A detailed history of Org Partners LLC transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Org Partners LLC holds 12,000 shares of CYDY stock, worth $2,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Holding current value
$2,760
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$0.12 - $0.35 $1,440 - $4,200
12,000 New
12,000 $2,000

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $187M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.